Saniona AB (publ)
STO: SANION.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Thomas Feldthus
- Employees
- 22
- Headquarters
- Glostrup, Denmark
- IPO year
- 2014
- Market cap
- SEK 1.9B
- Website
- https://www.saniona.com
Loading SANION…
Loading profile data…Frequently asked questions about SANION
What does Saniona AB (publ) (SANION.ST) do?
Saniona AB (publ), a rare disease biopharmaceutical company, engages in the research, development, and commercialization of treatments for the central nervous system in Denmark. The company's products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Ph...
Where does SANION.ST trade?
Saniona AB (publ) (SANION.ST) trades on the Stockholm Stock Exchange.
What sector is SANION.ST in?
Saniona AB (publ) (SANION.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Saniona AB (publ)?
Thomas Feldthus is the chief executive officer of Saniona AB (publ) (SANION.ST).
Where is Saniona AB (publ) headquartered?
Saniona AB (publ) is headquartered in Denmark.
Does SANION.ST pay a dividend?
Saniona AB (publ) (SANION.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SANION.ST go public?
Saniona AB (publ) (SANION.ST) completed its initial public offering in 2014.